Albuterol (salbutamol) | Albuterol-ipratropium | Arformoterol¶ | Budesonide | Fluticasone propionateΔ | Formoterol | Ipratropium bromide | Levalbuterol (Levosalbutamol) | Revefenacin | Sodium chloride 7% | |
Albuterol (salbutamol) | NR | NR | C | C* | NR | C* | NR | NR | C[1] | |
Albuterol-ipratropium | NR | NR | C*[2] | NR | NR | NR | NR | NR | NR | |
Arformoterol¶ | NR | NR | C[3] | NR | NR | C[3] | NR | NR | NR | |
Budesonide | C | C*[2] | C[3] | NR | C[3] | C | C[4] | NR | C◊ | |
Fluticasone propionateΔ | C* | NR | NR | NR | NR | C* | NR | NR | NR | |
Formoterol | NR | NR | NR | C[3] | NR | NR | NR | C[5,6] | NR | |
Ipratropium bromide | C* | NR | C[3] | C | C* | NR | C[4] | NR | C[1] | |
Levalbuterol (Levosalbutamol) | NR | NR | NR | C[4] | NR | NR | C[4] | NR | NR | |
Revefenacin | NR | NR | NR | NR | NR | C[5,6] | NR | NR | NR | |
Sodium chloride 7% | C[1] | NR | NR | C◊ | NR | NR | C[1] | NR | NR |
PF: preservative free; C: compatible; NR: not recommended due to insufficient data or simultaneous use is not clinically warranted.
* For this mixture, study data are available demonstrating that aerosol particle characteristics and drug mass output are similar to those conditions when each drug is nebulized separately.
¶ Not indicated for use in children.
Δ Nebulized formulation of fluticasone is available in many countries other than the United States and Canada.
◊ Physico-chemical compatibility determined with 5.85% hypertonic sodium chloride solution.Original figure modified for this publication. From: Kamin W, Erdnüss F, Krämer I. Inhalation solutions—Which ones may be mixed? Physico-chemical compatibility of drug solutions in nebulizers—Update 2013. J Cyst Fibros 2014; 13:243. Table used with the permission of Elsevier Inc. All rights reserved.